The Lewin Group

From TobaccoTactics
Revision as of 12:29, 22 January 2013 by Editor4 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

The Lewin Group is a US-based healthcare consultancy firm, and subsidiary to Quintiles Transnational (which provides clinical services to the pharmaceutical and biotech industries) [1] until it was sold to Ingenix in 2007.

Working for the tobacco industry

Previously secret internal tobacco industry documents suggest that in 2000 the UK office of The Lewin Group was commissioned by British American Tobacco (BAT) to describe the disease processes associated with smoking[2], and support the development of BAT’s harm reduction strategy. [3]. In its proposal, The Lewin Group suggested that public stakeholder dialogues on harm reduction could “provide a platform for further public relations”. [3]


  1. The Lewin Group, About us: The Lewin Group, Accessed January 2013
  2. P. Peeters and J Starzewski, Literature Review and Synthesis Reports: Disease Processes and Tobacco Smoking, 2000, Accessed January 2013
  3. 3.0 3.1 R. Walker, Proposal for the Development of a Harm Reduction Strategy (HRS), 2000, Accessed January 2013